Alto Neuroscience, Inc. Common Stock (ANRO)
R&D Expense Growth
-2.93%
Fiscal year · Period ending:
ANRO R&D Expense Growth
Latest reported-2.93%period ending
Latest reported-2.93%period ending
ANRO FY R&D Growth (YoY) (0.00% → -2.93%)
Latest values, visible window
High-resolution chart · PNG
ANRO r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -2.93% | |
| 55.1484% | |
| 27.8749% | |
| 183.0108% | |
| 0% |